Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 698

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 277KB)
Why become a member?
 

University researcher will receive millions for Fibromyalgia study

Thursday 11 November 2010

Wayne State UniversityUS news service 7 ABC Action News (xyz.com) reports:

A Wayne State University researcher will receive millions for Fibromyalgia study

Posted: 11/05/2010

DETROIT, Mich. (WXYZ) - A Wayne State University researcher is receiving a $3.4M grant for a new health study that focuses on Fibromyalgia.  The study is called "Pain and Stress Management for Fibromyalgia."

Mark A. Lumley, Ph.D., professor of psychology in the College of Liberal Arts and Sciences, received a five-year, $3,373,000 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.

Doctors from the University of Michigan Medical Center and St. John Providence Health System are also contributing to the study.

The study is aimed at finding out whether therapy that focuses on education, symptom management or confronting avoided emotional experiences is the best approach for fibromyalgia.

Fibromyalgia afflicts 2 to 4 percent of U.S. adults, mainly women. Fibromyalgia is marked by widespread muscular pain and tenderness, fatigue, sleep problems and mood disturbance.

The five-year grant will test three competing psychological/behavioral interventions for fibromyalgia: patient education, cognitive behavior therapy and a novel emotional awareness and exposure therapy.

Lumley and colleagues have developed and pilot-tested Emotional Exposure Therapy, which focuses on reducing stress by helping people confront emotions that they usually avoid. This is done through techniques such as expressive writing, mindfulness exercises and assertiveness training.

"Research has shown that the brain-and the pain that it generates-are greatly influenced by experiences and how people deal with their thoughts and emotions," Lumley said. "Our goal is to test the effects of helping patients understand their condition, cope with pain or resolve stress."

Recruitment for the study will begin in February 2011. Recruitment will be open to all patients with a diagnosis of Fibromyalgia. For information about participating in the study, contact the project manager at the Detroit/Southfield location at (313) 577-2258 or the Ann Arbor location at (866) 288-0046.

The above originally appeared here.

 


Arrow right

More Fibromyalgia News

 


Arrow right

More Multimedia

 


 

blog comments powered by Disqus
Previous Previous Page